Novel Use of Probenecid to Alleviate Symptoms of Opioid Withdrawal

NCT04939623 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Chronic Pain
Drug Dependence of Morphine Type
Symptom, Withdrawal

Interventions

DRUG: Probenecid

Sponsor

University of Calgary